Insights

Innovative Light XTi BioLights holds a strong patent moat with over 65 issued and 55 pending patents, indicating a defensible technology position. This presents an opportunity to position advanced light-therapy solutions to performance-focused teams and medical professionals seeking cutting-edge, protected modalities for sleep, recovery, and athletic performance.

Athlete Partnerships The company already collaborates with esteemed athletic programs to optimize sleep and recovery. This suggests a ready-made entry point for B2B outreach to sports teams, athletic clubs, universities, and professional programs seeking Performance/Recovery as a service or product integration for athletes.

Global Affiliate Network A robust affiliate program with medical professionals and wellness influencers implies ready-made channels for market expansion. Sales efforts can leverage clinician and influencer partnerships for co-marketing, certifications, and referral-driven pilots in clinics, wellness centers, and telehealth platforms.

Sustainability Focus XTi emphasizes sustainable progress and positive societal/environmental impact. This aligns with buyers prioritizing ESG-friendly vendors. Tailor proposals to highlight sustainable manufacturing, long-term durability, and measurable well-being outcomes to win over institutional buyers and wellness programs.

Tech Stack Readiness Existing tech stack (Shopify, payments, CRM/marketing tools) indicates a customer-friendly e-commerce and rapid deployment capability. This enables scalable pilots, direct-to-consumer campaigns, and enterprise-grade onboarding for clinics and teams seeking quick access to light-therapy solutions.

Similar companies to XTi

XTi Tech Stack

XTi uses 8 technology products and services including Shopify, Microsoft 365, Klaviyo, and more. Explore XTi's tech stack below.

Media & News

XTi's Email Address Formats

XTi uses at least 3 email formats:
XTi Email FormatsExamplePercentage
Last@xiantinc.comDoe@xiantinc.com
50%
First@xiantinc.comJohn@xiantinc.com
40%
First.Last@xiantinc.comJohn.Doe@xiantinc.com
10%

Frequently Asked Questions

What is XTi's phone number?

Minus sign iconPlus sign icon
You can contact XTi's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is XTi's stock symbol?

Minus sign iconPlus sign icon
XTi is a publicly traded company; the company's stock symbol is NEX.

What is XTi's official website and social media links?

Minus sign iconPlus sign icon
XTi's official website is xti.us and has social profiles on LinkedIn.

How much revenue does XTi generate?

Minus sign iconPlus sign icon
As of October 2026, XTi's annual revenue is estimated to be $1M - $10M.

What is XTi's SIC code and NAICS code?

Minus sign iconPlus sign icon
XTi's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does XTi have currently?

Minus sign iconPlus sign icon
As of October 2026, XTi has approximately 12 employees across 1 continents, including North America. Key team members include : R. P. Explore XTi's employee directory with LeadIQ.

What industry does XTi belong to?

Minus sign iconPlus sign icon
XTi operates in the Biotechnology Research industry.

What technology does XTi use?

Minus sign iconPlus sign icon
XTi's tech stack includes Shopify, Microsoft 365, Klaviyo, Apple Pay, Google Pay, PayPal, Venmo and X-Content-Type-Options.

What is XTi's email format?

Minus sign iconPlus sign icon
XTi's email format typically follows the pattern of Last@xiantinc.com. Find more XTi email formats with LeadIQ.

How much funding has XTi raised to date?

Minus sign iconPlus sign icon
As of October 2026, XTi has raised $27M in funding. The last funding round occurred on Dec 26, 2023.

When was XTi founded?

Minus sign iconPlus sign icon
XTi was founded in 2014.
XTi logo

XTi

Biotechnology ResearchColorado, United States11-50 Employees

XTi BioLights is a small biotechnology firm in Greeley, Colorado, focused on light-based therapies delivered through ocular exposure. Founded in 2014 by brothers Daren and Jason Suntych, the company promotes whole-body health outcomes through light therapy delivered via the eyes, positioning its approach as distinct from standard red light therapy. It maintains a substantial intellectual property portfolio, with more than 65 issued patents and 55 patents pending. 
The company collaborates with athletic programs and operates an international network of medical professionals and wellness influencers to expand access to its technology. By situating itself in the biotechnology research field, XTi emphasizes sustainable progress, integrating research insights with customer needs to support wellbeing and performance on a global scale.

Section iconCompany Overview

Phone number
Website
xti.us
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
NEX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $27M

    XTi has raised a total of $27M of funding over 5 rounds. Their latest funding round was raised on Dec 26, 2023 as a Venture Round.

  • $1M - $10M

    XTi's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.